Article

hamodia.com on 2019-02-13 23:43

Teva CEO Resolute Facing Bleak Numbers

Teva Pharmaceutical Industries’ share price was down over 11 percent in premarket trading on Wall Street on Wednesday after the company reported disappoint

Related news